Grebely J - Search Results

1

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?

Lima VD, Rozada I, Grebely J, Hull M, Lourenco L, Nosyk B, Krajden M, Yoshida E, Wood E, Montaner JS. Lima VD, et al. Among authors: grebely j. PLoS One. 2015 Dec 3;10(12):e0143836. doi: 10.1371/journal.pone.0143836. eCollection 2015. PLoS One. 2015. PMID: 26633652 Free PMC article.

2

Hepatitis C virus reinfection in injection drug users.

Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW. Grebely J, et al. Hepatology. 2006 Nov;44(5):1139-45. doi: 10.1002/hep.21376. Hepatology. 2006. PMID: 17058216

3

Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.

Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW. Grebely J, et al. Can J Gastroenterol. 2007 Jul;21(7):447-51. doi: 10.1155/2007/796325. Can J Gastroenterol. 2007. PMID: 17637948 Free PMC article.

4

Current approaches to HCV infection in current and former injection drug users.

Grebely J, deVlaming S, Duncan F, Viljoen M, Conway B. Grebely J, et al. J Addict Dis. 2008;27(2):25-35. doi: 10.1300/J069v27n02_04. J Addict Dis. 2008. PMID: 18681189 Review.

5

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

Grebely J, Raffa JD, Lai C, Krajden M, Kerr T, Fischer B, Tyndall MW. Grebely J, et al. J Viral Hepat. 2009 May;16(5):352-8. doi: 10.1111/j.1365-2893.2009.01080.x. Epub 2009 Feb 17. J Viral Hepat. 2009. PMID: 19226330

6

Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.

Grebely J, Raffa JD, Lai C, Kerr T, Fischer B, Krajden M, Dore GJ, Tyndall MW. Grebely J, et al. J Viral Hepat. 2011 Jan;18(1):32-41. doi: 10.1111/j.1365-2893.2010.01279.x. J Viral Hepat. 2011. PMID: 20196806

7

Reinfection with hepatitis C virus following sustained virological response in injection drug users.

Grebely J, Knight E, Ngai T, Genoway KA, Raffa JD, Storms M, Gallagher L, Krajden M, Dore GJ, Duncan F, Conway B. Grebely J, et al. J Gastroenterol Hepatol. 2010 Jul;25(7):1281-4. doi: 10.1111/j.1440-1746.2010.06238.x. J Gastroenterol Hepatol. 2010. PMID: 20594256

8

Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.

Grebely J, Matthews GV, Hellard M, Shaw D, van Beek I, Petoumenos K, Alavi M, Yeung B, Haber PS, Lloyd AR, Kaldor JM, Dore GJ; ATAHC Study Group. Grebely J, et al. J Hepatol. 2011 Jul;55(1):76-85. doi: 10.1016/j.jhep.2010.10.033. Epub 2010 Nov 23. J Hepatol. 2011. PMID: 21145855 Free PMC article. Clinical Trial.

9

Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.

Treloar C, Hull P, Bryant J, Hopwood M, Grebely J, Lavis Y. Treloar C, et al. Among authors: grebely j. Drug Alcohol Depend. 2011 Jul 1;116(1-3):52-6. doi: 10.1016/j.drugalcdep.2010.11.018. Epub 2010 Dec 30. Drug Alcohol Depend. 2011. PMID: 21194852

10

Treatment of acute HCV infection.

Grebely J, Matthews GV, Dore GJ. Grebely J, et al. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):265-74. doi: 10.1038/nrgastro.2011.32. Epub 2011 Mar 22. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21423258 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters